英文药名: Tarka (Trandolapril/Verapamil Sustained Release Tablets)
中文药名: 群多普利维拉帕米缓释片
品牌药生产厂家: Abbott
TARKA 2/180 Generic Name for TARKA 2/180 Trandolapril 2mg, verapamil HCl 180mg (ext-rel); tabs.
Legal Classification: Rx
Pharmacological Class for TARKA 2/180 ACE inhibitor + calcium channel blocker (diphenylalkylamine).
Manufacturer of TARKA 2/180 Abbott Laboratories
Indications for TARKA 2/180 Hypertension.
Adult dose for TARKA 2/180 Not for initial therapy. Titrate individual components. Take with food. ≥18yrs: 1 tab daily.
Children's dosing for TARKA 2/180 <18yrs: not recommended.
Also: TARKA 1/240 TARKA 2/240 TARKA 4/240
Contraindications for TARKA 2/180 History of ACEI-associated angioedema. Severe left ventricular (LV) dysfunction or LV dysfunction treated with β-blockers. Moderate to severe heart failure. Hypotension. Cardiogenic shock. Sick sinus syndrome, 2nd- or 3rd-degree AV block, unless paced. Atrial flutter or fibrillation and an accessory bypass tract. Pregnancy (Cat.D in 2nd and 3rd trimesters).
Warnings/Precautions for TARKA 2/180 Discontinue if laryngeal edema, angioedema, or jaundice occurs. Hepatic or renal dysfunction. Salt/volume depletion. CHF. Renal artery or aortic stenosis. Cerebrovascular or ischemic heart disease. Monitor liver function. Monitor for neutropenia in collagen vascular and/or renal disease and for hyperkalemia in diabetics. Dialysis (esp. high-flux membrane). Surgery. Black patients may have higher risk of angioedema than non-black patients. Control mild heart failure (eg, with digitalis, diuretics). AV conduction or neuromuscular transmission disorders. Hypertrophic cardiomyopathy. Pregnancy (Cat.C in 1st trimester). Nursing mothers: not recommended.
Interactions for TARKA 2/180 For trandolapril: Excessive hypotension with diuretics. Hyperkalemia with K+ supplements, K+-sparing diuretics, salt substitutes. May increase lithium levels. For verapamil: Potentiates alcohol, β-blockers, other antihypertensives, digitalis, theophylline, neuromuscular blockers, flecainide, carbamazepine, cyclosporine. Potentiated by grapefruit juice. Avoid disopyramide; quinidine in cardiomyopathy. Potentiated by CYP3A4 inhibitors (eg, erythromycin, ritonavir); antagonized by CYP3A4 inducers (eg, rifampin). Inhalation anesthetics may potentiate cardiac depression. May increase bleeding with aspirin. Monitor theophylline, lithium.
Adverse Reactions for TARKA 2/180 Cough, AV block, constipation, dizziness, elevated liver enzymes, fatigue, chest pain, bradycardia, joint pain, GI upset, bronchitis, dyspnea, pain in extremities, paralytic ileus.
How is TARKA 2/180 supplied? Tabs—100
 通用名称塔卡180分之2 群多普利2毫克,180毫克盐酸维拉帕米(内线- REL的);标签。
法律分类: 接收
药理班塔卡2/180 ACE抑制剂+钙通道阻滞剂(diphenylalkylamine)。
制造商塔卡2/180 雅培公司
适应症塔卡2/180 高血压。
成人剂量塔卡2/180 不适用于初步治疗。滴定单个组件。随身携带的食物。 ≥18yrs:1标签日报。
儿童剂量为塔卡2/180
“18yrs:不推荐。
另外: 塔卡二百四分之一 塔卡二百四十〇分之二 塔卡二百四十○分之四
禁忌症为塔卡180分之2 血管紧张素转换酶抑制剂的历史相关的血管性水肿。严重左心室(LV)功能不全或左室功能障碍的β-受体阻滞剂治疗。中度至重度心力衰竭。低血压。心源性休克。病态窦房结综合征,第二或第三度房室传导阻滞,除非节奏。心房扑动或颤动和从犯旁路道。妊娠(Cat.D在第二和第三孕期)。
警告/注意事项塔卡2/180 如果停止喉头水肿,血管性水肿,或黄疸发生。肝,肾功能不全。盐/容量减少。瑞士法郎。肾动脉或主动脉瓣狭窄。脑血管或缺血性心脏病。监测肝功能。监控胶原血管和/或肾脏疾病在糖尿病患者中性粒细胞和高钾血症。透析(尤其是高通量膜)。手术。黑人患者可能有更高的比非黑人患者的血管性水肿的危险。控制轻度心力衰竭(如洋地黄,利尿剂)。房室传导或神经肌肉传递障碍。肥厚性心肌病。怀孕(在第一学期Cat.C)。哺乳母亲:不推荐。
互作塔卡180分之2 对于群多普利:过度使用利尿剂低血压。高钾血症与K +的补充,钾利尿剂,代盐。可能会增加锂的水平。对于维拉帕米:Potentiates醇,β-阻断剂,其他抗高血压药,洋地黄,茶碱,神经肌肉阻断剂,氟卡尼,卡马西平,环孢素。 Potentiated的葡萄柚汁。避免丙吡胺,奎尼丁在心肌病。 Potentiated被CYP3A4抑制剂(如红霉素,利托那韦),由CYP3A4的诱导剂(如利福平)拮抗。吸入麻醉剂,会增强心脏抑郁症。阿司匹林可能会增加出血。监测茶碱,锂。
为塔卡一百八十○分之二不良反应 咳嗽,房室传导阻滞,便秘,头晕,肝酶升高,疲劳,胸痛,心动过缓,关节疼痛,胃肠不适,支气管炎,呼吸困难,四肢疼痛,麻痹性肠梗阻。
如何塔卡2/180提供? 制表- 100 |